Clinical Trial

Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL

Name: Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL — clinical trial record (NCT07744737)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of pirtobrutinib combined with R-CHOP in patients with newly diagnosed non-GCB diffuse large B-cell lymphoma (DLBCL)

Trial Details

NCT Number	NCT07744737
Lead Sponsor	Changzhou No.2 People's Hospital
Conditions	DLBCL - Diffuse Large B Cell Lymphoma, R-CHOP Chemotherapy, Pirtobrutinib
Enrollment	34 participants
Start Date	2026-07-30
Primary Completion	2027-07-30 (estimated)
Study Completion	2029-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-06